Arbutus Biopharma Corporation (ABUS): $abus A fair amount of attention has bee...

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	3160
Posts	967854
Boards Moderated	152
Alias Born	09/04/2000

mick

Re: aries4747 post# 6432

Tuesday, 10/05/2021 9:13:06 AM

Tuesday, October 05, 2021 9:13:06 AM

$abus A fair amount of attention has been on Arbutus versus Moderna, believe it or not. The two conflicted over Arbutus’s lipid formulations for nucleic acid delivery.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ABUS News

Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:10 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 11:30:44 AM
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute • IH Market News • 03/04/2026 11:24:49 AM
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:01:31 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:34 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 12:41:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 01:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 12:31:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 12:31:10 PM
Arbutus Reports Third Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2025 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 12:01:34 PM
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025 • GlobeNewswire Inc. • 10/07/2025 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2025 01:00:46 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 08/13/2025 09:40:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2025 08:08:29 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2025 08:06:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2025 11:32:07 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 11:31:30 AM
Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/06/2025 11:30:00 AM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ABUS News

More ABUS News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ABUS News

Go Ad-Free